From the organizers:
Course Description
Preclinical research aims to develop potential therapies and to translate scientific discoveries into clinical applications for patients. This process requires rigorous hypothesis testing and experimentation in model systems to confirm treatment efficacy and safety before advancing to clinical trials. However, translational failures where clinical trials fail to replicate promising preclinical results are common, creating a significant gap with medical, economic, social, and ethical consequences.
Concerns about the low success rate of translating preclinical research into effective clinical interventions has grown within the biomedical community.
Learning Objectives
As part of the DECIDE II project, this seminar series brings together international experts to share insights on robust and efficient practices for responsible preclinical research, with the aim of bridging the translational gap and strengthening the research community.
If you were unable to attend a webinar session, you can access the slides and the recorded session here.
Target Audience
- Research fellows, early career researcher (postdocs, PhDs, students)
- Members of BIH, CHA, BUA and external institutions (academia, industry, other organizations)
Participation Requirements
None.
Upcoming Lectures
April 14, 2026: Cancer-SOLES: A Systematic Online Living Evidence Summary of Preclinical Cancer Research
May 12, 2026: Born To Be Wild – Wildlings, a Novel Translational Research Model for Human Diseases
June 9, 2026: A New Refinement Strategy to Oral Gavage: The Micropipette-Guided Drug Administration (MDA) Method
July 7, 2026: Organoid Intelligence - Exploring Brain Organoids and Artificial Intelligence (AI)